drugset / Trial / NCT07625280
A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
Phase 3
Not yet recruiting
108 enrolled
Jazz Pharmaceuticals
Jazz Pharmaceuticals Ireland Limited · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of expanded Xywav dosing regimens in adult participants with narcolepsy or idiopathic hypersomnia (IH).
Timeline
- Start
- 2026-06-30
- Primary completion
- 2027-12-23
- Completion
- 2028-01-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sodium Oxybate | Unknown | — | Oral |